LungLife AI Inc (LLAI.L)
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
Company Info
ISIN | USU5500L1045 |
---|---|
Sector | Healthcare |
Industry | Diagnostics & Research |
Highlights
Market Cap | £7.97M |
---|---|
EPS | -£0.17 |
Revenue (TTM) | £46.00K |
Gross Profit (TTM) | £24.00K |
EBITDA (TTM) | -£5.38M |
Year Range | £19.00 - £142.10 |
Target Price | £2.27 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in LungLife AI Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
LungLife AI Inc had a return of -53.26% year-to-date (YTD) and -57.00% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -53.26% | 11.18% |
1 month | -30.65% | 5.60% |
6 months | -74.71% | 17.48% |
1 year | -57.00% | 26.33% |
5 years (annualized) | N/A | 13.16% |
10 years (annualized) | N/A | 10.99% |
Monthly Returns
The table below presents the monthly returns of LLAI.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -7.61% | -2.35% | -27.71% | -5.00% | -53.26% | ||||||||
2023 | 5.88% | -16.67% | 3.33% | -27.10% | -24.78% | -40.00% | 139.22% | 47.54% | -5.56% | 5.88% | -1.11% | -48.31% | -45.88% |
2022 | 0.00% | -1.60% | -5.41% | -8.57% | -7.81% | -1.69% | -10.34% | -5.77% | -4.08% | 7.23% | -12.70% | -22.73% | -54.79% |
2021 | -2.20% | 0.00% | -1.50% | -5.06% | 2.67% | -2.34% | -8.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of LLAI.L is 21, indicating that it is in the bottom 21% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
LLAI.L (LungLife AI Inc)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for LungLife AI Inc (LLAI.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the LungLife AI Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the LungLife AI Inc was 90.73%, occurring on Jul 13, 2023. The portfolio has not yet recovered.
The current LungLife AI Inc drawdown is 89.51%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-90.73% | Jul 9, 2021 | 505 | Jul 13, 2023 | — | — | — |
Volatility
Volatility Chart
The current LungLife AI Inc volatility is 21.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |